Cargando…
CO103 Real-World Effectiveness of Sotrovimab for the Early Treatment of COVID-19: Evidence from the National COVID Cohort Collaborative (N3C)
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256536/ http://dx.doi.org/10.1016/j.jval.2023.03.176 |
| _version_ | 1785057126116229120 |
|---|---|
| author | Bell, C. Bobbili, P. Desai, R. Gibbons, D. Patel, V. DerSarkissian, M. Drysdale, M. Birch, H. Lloyd, E. Zhang, A. Duh, M.S. |
| author_facet | Bell, C. Bobbili, P. Desai, R. Gibbons, D. Patel, V. DerSarkissian, M. Drysdale, M. Birch, H. Lloyd, E. Zhang, A. Duh, M.S. |
| author_sort | Bell, C. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10256536 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-102565362023-06-12 CO103 Real-World Effectiveness of Sotrovimab for the Early Treatment of COVID-19: Evidence from the National COVID Cohort Collaborative (N3C) Bell, C. Bobbili, P. Desai, R. Gibbons, D. Patel, V. DerSarkissian, M. Drysdale, M. Birch, H. Lloyd, E. Zhang, A. Duh, M.S. Value Health Article Elsevier 2023-06 2023-06-10 /pmc/articles/PMC10256536/ http://dx.doi.org/10.1016/j.jval.2023.03.176 Text en Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Bell, C. Bobbili, P. Desai, R. Gibbons, D. Patel, V. DerSarkissian, M. Drysdale, M. Birch, H. Lloyd, E. Zhang, A. Duh, M.S. CO103 Real-World Effectiveness of Sotrovimab for the Early Treatment of COVID-19: Evidence from the National COVID Cohort Collaborative (N3C) |
| title | CO103 Real-World Effectiveness of Sotrovimab for the Early Treatment of COVID-19: Evidence from the National COVID Cohort Collaborative (N3C) |
| title_full | CO103 Real-World Effectiveness of Sotrovimab for the Early Treatment of COVID-19: Evidence from the National COVID Cohort Collaborative (N3C) |
| title_fullStr | CO103 Real-World Effectiveness of Sotrovimab for the Early Treatment of COVID-19: Evidence from the National COVID Cohort Collaborative (N3C) |
| title_full_unstemmed | CO103 Real-World Effectiveness of Sotrovimab for the Early Treatment of COVID-19: Evidence from the National COVID Cohort Collaborative (N3C) |
| title_short | CO103 Real-World Effectiveness of Sotrovimab for the Early Treatment of COVID-19: Evidence from the National COVID Cohort Collaborative (N3C) |
| title_sort | co103 real-world effectiveness of sotrovimab for the early treatment of covid-19: evidence from the national covid cohort collaborative (n3c) |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256536/ http://dx.doi.org/10.1016/j.jval.2023.03.176 |
| work_keys_str_mv | AT bellc co103realworldeffectivenessofsotrovimabfortheearlytreatmentofcovid19evidencefromthenationalcovidcohortcollaborativen3c AT bobbilip co103realworldeffectivenessofsotrovimabfortheearlytreatmentofcovid19evidencefromthenationalcovidcohortcollaborativen3c AT desair co103realworldeffectivenessofsotrovimabfortheearlytreatmentofcovid19evidencefromthenationalcovidcohortcollaborativen3c AT gibbonsd co103realworldeffectivenessofsotrovimabfortheearlytreatmentofcovid19evidencefromthenationalcovidcohortcollaborativen3c AT patelv co103realworldeffectivenessofsotrovimabfortheearlytreatmentofcovid19evidencefromthenationalcovidcohortcollaborativen3c AT dersarkissianm co103realworldeffectivenessofsotrovimabfortheearlytreatmentofcovid19evidencefromthenationalcovidcohortcollaborativen3c AT drysdalem co103realworldeffectivenessofsotrovimabfortheearlytreatmentofcovid19evidencefromthenationalcovidcohortcollaborativen3c AT birchh co103realworldeffectivenessofsotrovimabfortheearlytreatmentofcovid19evidencefromthenationalcovidcohortcollaborativen3c AT lloyde co103realworldeffectivenessofsotrovimabfortheearlytreatmentofcovid19evidencefromthenationalcovidcohortcollaborativen3c AT zhanga co103realworldeffectivenessofsotrovimabfortheearlytreatmentofcovid19evidencefromthenationalcovidcohortcollaborativen3c AT duhms co103realworldeffectivenessofsotrovimabfortheearlytreatmentofcovid19evidencefromthenationalcovidcohortcollaborativen3c |